[1]
Degli Esposti, E. and Tomic, R. 2012. Clinical and economic impact of aliskiren in uncontrolled hypertensive patients. Farmeconomia. Health economics and therapeutic pathways. 13, 1 (Mar. 2012), 15–23. DOI:https://doi.org/10.7175/fe.v13i1.199.